Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gallbladder woes may complicate ERCP recovery, study finds

NCT ID NCT04242394

Knowledge-focused Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed over 1,000 people who had an ERCP procedure to see if having chronic gallbladder disease increases the chance of complications like infection or inflammation. Researchers tracked issues such as post-ERCP cholecystitis, pancreatitis, and cholangitis. The goal is to help doctors better predict and manage risks for patients with gallbladder problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify patients at higher risk for post-ERCP complications, leading to better monitoring or preventive care.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly lead to a new therapy. Results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,019 people

The number who actually took part.

Started

Feb 2020

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Common bile duct stone ERCP patients with gallbladder in situ

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ERCP patients with gallbladder in situ Exclusion Criteria: * Acute cholecystitis before surgery * Gallbladder has been removed * Gastrointestinal reconstruction * Unwillingness or inability to consent for the study * Unstable vital signs Coagulation dysfunction (INR\>1.5) * Low peripheral blood platelet count (\<50×10 \^9 / L) or using anti-coagulation drugs * Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease (such as decompensated liver cirrhosis, liver failure and so on), septic shock Biliary- duodenal fistula confirmed during ERCP * Pregnant women or breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cholecystitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cholecystitis cholecystolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cholecystitis

Contacts and locations

Locations

  • Chinese herb medicine hospital of Longnan City

    Longnan, Gansu, 746000, China

  • The first hospital of Tianshui

    Tianshui, Gansu, 741000, China

  • Wuwei turmour hospital

    Wuwei, Gansu, 733000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.